News | April 02, 2024
Apotex to acquire Canadian Searchlight Pharma
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)